for the 2ndquarter of Year 2017 and 2018 were in amounts of Baht 126.83 million and Baht 135.14 million, respectively, which increased by 6.5% compared to the total revenue. The revenue from In-patients

-patients and Out-patients department inclined by 31.5 % and 5.9 % respectively. Causing from Gastrointestinal diseases and Dengue Fever including non-communicable diseases such as cardiovascular disease

in number of OPD and IPD patients. 2. An increase in other income mainly from interest revenues. The financial position of the Company according to the consolidated financial statements as of December

has decreased by 6.30% despite total hospital income from general patients increased 8.69% compared with the same period of last year. This is mainly due to the medical-service-fee adjustment caused by

to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q2/2018 were Baht 1,240 million which increased from the Q2/2017 by Baht 190.6 million or 18.2% as a result of the

11.6% due to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q3/2018 were Baht 1,474.0 million which increased from Q3/2017 by Baht 201.9 million or 15.9% as a result of

million or 11.6% due to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q3/2018 were Baht 1,518.9 million which increased from Q3/2017 by Baht 245.3 million or 19.3% as a

year-over-year from Baht 188.13 million in 3Q18. This was mostly due to an increase in revenues from Inpatients, Outpatients and IVF patients. The Company reported Cost of Hospital Operations (including

; including operate clinical business which dialysis services for kidney patients who receive replacement therapy with dialysis by dialysis machinery (Dialysis Center) and distribution of medical equipment

treatment system; including operate clinical business which dialysis services for kidney patients who receive replacement therapy with dialysis by dialysis machinery (Dialysis Center) and distribution of